Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Nebulizers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028" report has been added to ResearchAndMarkets.com's offering. This report on the global nebulizers market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028.

The report provides revenue of the global nebulizers market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global nebulizers market during the forecast period. The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global nebulizers market. Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global nebulizers market. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global nebulizers market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global nebulizers market. The report delves into the competitive landscape of the global nebulizers market. Key players operating in the global nebulizers market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global nebulizers market that have been profiled in this report. Key Questions Answered in Nebulizers Market Report

What is the scope of growth of product companies in the global nebulizers market?

What will be the Y-o-Y growth of the global nebulizers market between 2017 and 2028?

What is the influence of changing trends in technologies on the global nebulizers market?

Will North America be the most profitable market for nebulizer device providers?

Which factors are anticipated to hamper the growth of the global nebulizers market during the forecast period?

Which are the leading companies in the global nebulizers market?

Key Topics Covered: 1. Preface 2. Assumptions and Research Methodology 3. Executive Summary: Global Nebulizers Market 4. Market Overview 4.1. Introduction 4.2. Overview 4.3. Market Dynamics 4.4. Global Nebulizers Market Analysis and Forecast, 2017-2028 5. Key Insights 5.1. Technological Advancements 5.2. Porters Five Forces Analysis 5.3. Key Industry Developments 5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact) 6. Global Nebulizers Market Analysis and Forecast, by Product Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Type, 2017-2028 6.4. Market Attractiveness Analysis, by Type 7. Global Nebulizers Market Analysis and Forecast, by Region 7.1. Key Findings 7.2. Market Value Forecast, by Region 7.3. Market Attractiveness Analysis, by Region 8. North America Nebulizers Market Analysis and Forecast 8.1. Introduction 8.2. Market Value Forecast, by Type, 2017-2028 8.3. Market Value Forecast, by Country, 2017-2028 8.4. Market Attractiveness Analysis 9. Europe Nebulizers Market Analysis and Forecast 9.1. Introduction 9.2. Market Value Forecast, by Type, 2017-2028 9.3. Market Value Forecast, by Country/Sub-region, 2017-2028 9.4. Market Attractiveness Analysis 10. Asia Pacific Nebulizers Market Analysis and Forecast 10.1. Introduction 10.2. Market Value Forecast, by Type, 2017-2028 10.3. Market Value Forecast, by Country/Sub-region, 2017-2028 10.4. Market Attractiveness Analysis 11. Latin America Nebulizers Market Analysis and Forecast 11.1. Introduction 11.2. Market Value Forecast, by Type, 2017-2028 11.3. Market Value Forecast, by Country/Sub-region, 2017-2028 11.4. Market Attractiveness Analysis 12. Middle East & Africa Nebulizers Market Analysis and Forecast 12.1. Introduction 12.2. Market Value Forecast, by Type, 2017-2028 12.3. Market Value Forecast, by Country/Sub-region, 2017-2028 12.4. Market Attractiveness Analysis 13. Competition Landscape 13.1. Market Player - Competition Matrix (by tier and size of companies) 13.2. Company Profiles Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/grxqj9

As we move toward the end of Q2, it’s time to start thinking about earnings. Looking back at the quarter, analysts are predicting earnings growth of 8%, which may rise to 11% heading into next year. It’s a rosy picture, but it’s also not a sure thing. GDP contracted in Q1, by nearly 1.5%, and some estimates are showing 0% growth in Q2. Such results would meet the technical definition of a recession – and recession is hardly the usual environment to find robust earnings growth. Looking at current

Shares of the specialty pharmaceutical company Bausch Health Companies (NYSE: BHC) are surging today in response to the news that Joseph Papa has resigned from the board of directors effective immediately. Over the past six years, Papa has been instrumental in lowering the company's sky-high debt and keeping it out of bankruptcy court. Bausch said in a statement Thursday evening that billionaire hedge fund manager John Paulson will fill the vacant board position.

Nuclear submarine supplier to be sold to US buyer after diplomatic row Russian default expected within days Retail sales volumes down 0.5pc in May FTSE 100 rises strongly Ambrose Evans-Pritchard: The pro-Brussels establishment is painting Brexit as an economic disaster to reverse it Sign up here for our daily business briefing newsletter

“Time is running out for cash-burning companies kept afloat with easy access to capital,” New Constructs CEO David Trainer said in a Thursday research note.

Tesla plant near Shanghai is going to shut down temporarily, according to reports. On Wednesday, Reuters reported that Tesla (ticker: TSLA) will shut down production in China for a couple of weeks at the start of July to upgrade equipment. Tesla didn’t return a request for comment.

High-yield dividend stocks are a major component of my stock portfolio. Here are three income stocks that have room for solid gains in the next year and even better gains over the long run. The blue-chip business development company (BDC) Main Street Capital (NYSE: MAIN) has held up better than the S&P 500 index, which is down 21% so far this year.

At current levels, investors need a 7% to 8% return just to preserve their wealth.

Shares of CalAmp (NASDAQ: CAMP) were tumbling today after the company reported first-quarter results that missed Wall Street's top- and bottom-line expectations. CalAmp reported a non-GAAP (adjusted) loss per share of $0.10 in the quarter, which was much worse than analysts' consensus estimate of a loss of $0.03. The company's revenue of $64.7 million -- a decrease of nearly 19% from the year-ago quarter -- was also below Wall Street's average estimate of $69.4 million.

In this article, we will look at 10 stocks to profit from inflation. If you want to explore similar stocks, you can also read 5 Stocks to Profit from Inflation. Billionaire investor and hedge fund manager of the world’s largest hedge fund, Bridgewater Associates, Ray Dalio shared his views on the current economic situation that […]

The merger between the special-purpose acquisition company Gores Guggenheim and the electric-vehicle company coming from Volvo is done.

Weitz Investment Management, an investment management firm, published its “Partners III Opportunity Fund” first quarter 2022 investor letter – a copy of which can be downloaded here. The Partners III Opportunity Fund’s Institutional Class returned -5.09% in the first quarter of 2022 compared with -4.60% for the S&P 500 and -5.28% for the Russell 3000. […]

Shares of Meta Platforms (NASDAQ: META), the parent company of Facebook, were rising quickly today on seemingly no company-specific news. Instead, a rebound in the tech sector appears to be sending Meta's stock higher today. The tech stock had gained 5.8% as of 1:22 p.m. ET on Friday.

Energy prices are high. But bargain-hunter Buffett continues to bet on big oil.

Downturns can bring a lot of pain, but they can also bring on plenty of opportunities, as lower stock prices start making costs of entry more attractive. Before taking advantage of these opportunities, however, investors need to find a recognizable signal that will set them apart. One popular signal to follow is the insider buying, the trades made by high-ranking company officers whose positions give them the ‘inside’ track on their company’s likely prospects – and therefore, of the stock’s pros

Distillate Capital Partners LLC, an investment management firm, published its first-quarter 2022 investor letter – a copy of which can be downloaded here. Distillate’s U.S. FSV outperformed S&P 500 in the first quarter of 2022 with a return of -3.60% net of fees versus -4.60% for the benchmark. Since its inception in 2017, annualized performance […]

Yahoo Finance Live checks out Carnival Cruise Lines' stock ahead of its earnings report tomorrow.

US stocks rose Friday morning, with the S&P 500 on track to end a three-week losing streak as investors digested Federal Reserve officials' latest affirmations that they remained committed to bringing down inflation.

Enbridge (NYSE: ENB) is offering a sizable 6.7% dividend yield today. The dividend has been increased annually for 27 consecutive years, putting the company in the Dividend Aristocrat space. The core of Enbridge's business is its oil and natural gas pipelines, which make up 58% and 26% of earnings before interest, taxes, depreciation, and amortization (EBITDA), respectively.

(Bloomberg) -- The S&P 500 Index may have another 24% to fall by year-end, if the past 150 years of financial-market history are any guide.Most Read from BloombergJuul’s Vaping Products Are Ordered Off the Market in the USThese Are the World’s Most Liveable Cities in 2022Elon Musk Says New Tesla Plants Are ‘Money Furnaces’ Losing BillionsRecession Worries Boost Treasuries; Stocks Advance: Markets WrapThe World’s Bubbliest Housing Markets Are Flashing Warning SignsThat’s according to Societe Gene

Rivian Automotive (NASDAQ: RIVN) has been a widely followed electric vehicle (EV) stock since its successful IPO last fall. Investors should keep an eye on how much production is expected to improve in 2023 once the company offers guidance.